These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 15901902

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.
    van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE.
    Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477
    [Abstract] [Full Text] [Related]

  • 23. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis.
    Poór G, Nagy ZB, Schmidt Z, Brózik M, Merétey K, Gergely P.
    Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417
    [Abstract] [Full Text] [Related]

  • 24. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
    Cha S, Choi CB, Han TU, Kang CP, Kang C, Bae SC.
    Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
    [Abstract] [Full Text] [Related]

  • 25. Role of anticyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test?
    Panchagnula R, Rajiv SR, Prakash J, Chandrashekara S, Suresh KP.
    J Clin Rheumatol; 2006 Aug; 12(4):172-5. PubMed ID: 16891919
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Antibodies to cyclic citrullinated peptides in psoriatic arthritis.
    Bogliolo L, Alpini C, Caporali R, Scirè CA, Moratti R, Montecucco C.
    J Rheumatol; 2005 Mar; 32(3):511-5. PubMed ID: 15742445
    [Abstract] [Full Text] [Related]

  • 28. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.
    Kokkonen H, Johansson M, Innala L, Jidell E, Rantapää-Dahlqvist S.
    Arthritis Res Ther; 2007 Mar; 9(3):R56. PubMed ID: 17553139
    [Abstract] [Full Text] [Related]

  • 29. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis.
    Sihvonen S, Korpela M, Mustila A, Mustonen J.
    J Rheumatol; 2005 Nov; 32(11):2089-94. PubMed ID: 16265684
    [Abstract] [Full Text] [Related]

  • 30. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis.
    Inanc N, Dalkilic E, Kamali S, Kasapoglu-Günal E, Elbir Y, Direskeneli H, Inanc M.
    Clin Rheumatol; 2007 Jan; 26(1):17-23. PubMed ID: 16538391
    [Abstract] [Full Text] [Related]

  • 31. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A, Plischke H, Kellner H, Gruber R.
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [Abstract] [Full Text] [Related]

  • 32. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F, Çapkin E, Karkucak M, Yücel B, Sönmez M, Alver A, Kaklikkaya N, Tosun M, Alemdaroğlu E, Solak M.
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Women with rheumatoid arthritis negative for anti-cyclic citrullinated peptide and rheumatoid factor are more likely to improve during pregnancy, whereas in autoantibody-positive women autoantibody levels are not influenced by pregnancy.
    de Man YA, Bakker-Jonges LE, Goorbergh CM, Tillemans SP, Hooijkaas H, Hazes JM, Dolhain RJ.
    Ann Rheum Dis; 2010 Feb; 69(2):420-3. PubMed ID: 19282308
    [Abstract] [Full Text] [Related]

  • 35. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.
    Alessandri C, Bombardieri M, Papa N, Cinquini M, Magrini L, Tincani A, Valesini G.
    Ann Rheum Dis; 2004 Oct; 63(10):1218-21. PubMed ID: 15361374
    [Abstract] [Full Text] [Related]

  • 36. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
    Galati S, Beauvillain C, Renier G, Jeannin P, Masson C, Chevailler A.
    Ann Biol Clin (Paris); 2008 Oct; 66(2):157-64. PubMed ID: 18390426
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts.
    Lee HS, Irigoyen P, Kern M, Lee A, Batliwalla F, Khalili H, Wolfe F, Lum RF, Massarotti E, Weisman M, Bombardier C, Karlson EW, Criswell LA, Vlietinck R, Gregersen PK.
    Arthritis Rheum; 2007 Jun; 56(6):1745-53. PubMed ID: 17530703
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.